CAS
CRMD icon

Coppell Advisory Solutions’s CorMedix CRMD Stock Holding History

Coppell Advisory Solutions’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-145,392
Closed -$1.72M – 397
2025
Q3 		$1.72M Buy
+145,392
New +$1.76M 0.18% 122

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Coppell Advisory Solutions's CRMD Position: Q4 2025 in Review

Coppell Advisory Solutions sold out of CorMedix (CRMD) in Q4 2025, closing a stake of 145,392 shares — an estimated $1.72M sold.

Coppell Advisory Solutions first reported a position in CRMD in Q3 2025 and held it in 1 quarter. The position peaked at $1.72M in Q3 2025. 198 funds tracked by Wall St. Rank hold CRMD as of Q4 2025.

  • Coppell Advisory Solutions reported no remaining CorMedix position as of Q4 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 145,392 CorMedix shares in Q4 2025, an estimated $1.72M.
  • Coppell Advisory Solutions first reported a position in CorMedix in Q3 2025 and held it in 1 quarter.
  • Coppell Advisory Solutions's CorMedix position peaked at $1.72M in Q3 2025.
  • 198 funds tracked by Wall St. Rank held CorMedix as of Q4 2025.

Based on Coppell Advisory Solutions's 13F filing for Q4 2025, filed 17 Feb 2026.